Request Demo
Last update 10 Mar 2026
CD123-CD33 cCAR T cell therapy(iCell Gene Therapeutics, Inc.)
Last update 10 Mar 2026
Overview
Basic Info
Drug Type CAR-T |
Synonyms CD123-CD33 cCAR, ICG-136, ICG136 |
Target |
Action inhibitors |
Mechanism CD123 inhibitors(Interleukin-3 receptor subunit alpha inhibitors), CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with CD123-CD33 cCAR T cell therapy(iCell Gene Therapeutics, Inc.)NCT04156256
Phase I, Interventional, Single Arm, Open Label, Treatment Study to Evaluate The Safety and Tolerability of CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies
100 Clinical Results associated with CD123-CD33 cCAR T cell therapy(iCell Gene Therapeutics, Inc.)
Login to view more data
100 Translational Medicine associated with CD123-CD33 cCAR T cell therapy(iCell Gene Therapeutics, Inc.)
Login to view more data
100 Patents (Medical) associated with CD123-CD33 cCAR T cell therapy(iCell Gene Therapeutics, Inc.)
Login to view more data
100 Deals associated with CD123-CD33 cCAR T cell therapy(iCell Gene Therapeutics, Inc.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | Phase 1 | China | 01 Mar 2018 | |
| Anemia, Refractory, With Excess of Blasts | Phase 1 | China | 01 Mar 2018 | |
| Chronic Myelogenous Leukemia | Phase 1 | China | 01 Mar 2018 | |
| Myelodysplastic Syndromes | Phase 1 | China | 01 Mar 2018 | |
| Myeloproliferative Disorders | Phase 1 | China | 01 Mar 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free